Corrigendum to “Biomonitoring Equivalents for Molybdenum” [Regul. Toxicol. Pharmacol. 77 (2016) 223–229, (Regulatory Toxicology and Pharmacology (2016) 77(223-229) (S0273230016300460), (10.1016/j.yrtph.2016.03.004));Biomonitoring Equivalents for molybdenum

Regulatory Toxicology and Pharmacology

Volumn 77, Issue , 2016, Pages 223-229

  Hays, Sean M ^a   Macey, Kristin ^b   Poddalgoda, Devika ^b   Lu, Ming ^b   Nong, Andy ^b   Aylward, Lesa L ^a  

^a LLP   (United States)

^b HEALTH CANADA   (Canada)

Author keywords

Biomonitoring; Biomonitoring Equivalents; Molybdenum; Risk assessment

Indexed keywords

MOLYBDENUM; BIOLOGICAL MARKER; POLLUTANT; TRACE ELEMENT;

ARTICLE; BIOLOGICAL MONITORING; BIOMONITORING EQUIVALENT; BLOOD LEVEL; CHEMICAL PARAMETERS; CONTROLLED STUDY; EXPOSURE; NUTRITION; PRIORITY JOURNAL; TOXICITY ASSAY; URINE LEVEL; ADVERSE EFFECTS; AGE; ANIMAL; BIOLOGICAL MODEL; BLOOD; CANADA; DIETARY REFERENCE INTAKE; DOSE RESPONSE; ENVIRONMENTAL MONITORING; FEMALE; HUMAN; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; NUTRITIONAL STATUS; PHARMACOKINETICS; POLLUTANT; PROCEDURES; RISK ASSESSMENT; SPECIES DIFFERENCE; URINE;

AGE FACTORS; ANIMALS; BIOMARKERS; CANADA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; MOLYBDENUM; NO-OBSERVED-ADVERSE-EFFECT LEVEL; NUTRITIONAL STATUS; RECOMMENDED DIETARY ALLOWANCES; RISK ASSESSMENT; SPECIES SPECIFICITY; TRACE ELEMENTS;

EID: 84961725608     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2022.105212     Document Type: Erratum

References (39)

1. Angerer J., Aylward L.L., Hays S.M., Heinzow B., Wilhelm M. Human biomonitoring assessment values: approaches and data requirements. Int. J. Hyg. Environ. Health 2011 Sep, 214(5):348-360.
2. Aylward L.L., Kirman C.R., Adgate J.L., McKenzie L.M., Hays S.M. Interpreting variability in population biomonitoring data: role of elimination kinetics. J. Expos Sci. Environ. Epidemiol. 2012, 22:398-408.
3. Aylward L.L., Hays S.M., Smolders R., Holger Koch, Cocker J., Jones K., Warren N., Levy L., Bevan R. Sources of variability in biomarker concentrations. J. Toxicol. Environ. Health B Crit. Rev. 2014, 17(1):45-61.
4. Aylward L.L., Hays S.M., Vezina A., Deveau M., St-Amand A., Nong A. Biomonitoring Equivalents for interpretation of urinary fluoride. Regul. Toxicol. Pharmacol. 2015 Jun, 72(1):158-167.
5. European Commission, Scientific Committee on Food Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Molybdenum 2000, European Commission, Brussels, SCF/CS/NUT/UPPLEV/22 Final Report.
6. EFSA (European Food Safety Authority) Scientific opinion on dietary reference values for molybdenum. EFSA J. 2013 2013, 11(8):3333.
7. Fungwe T.V., Buddingh F., Demick D.S., Lox C.D., Yang M.T., Yang S.P. The role of dietary molybdenum on estrous activity, fertility, reproduction and molybdenum and copper enzyme activities of female rats. Nutr. Res. 1990, 10:515-524.
8. Giussani A. A recycling systemic model for the biokinetics of molybdenum radionuclides. Sci. Total Environ. 2008, 404(1):44-55.
9. Giussani A., Cantone M.C., Höllriegl V., Oeh U., Tavola F., Veronese I. Modelling urinary excretion of molybdenum after oral and intravenous administration of stable tracers. Radiat. Prot. Dosim. 2007, 127(1-4):136-139. Epub 2007 Jun 8. PubMed PMID: 17561520.
10. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 2007 Feb, 47(1):96-109.
11. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk C., DiZio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W. Biomonitoring equivalents expert workshop. Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop. Regul. Toxicol. Pharmacol. 2008 Aug, 51(3 Suppl. l):S4-S15.
12. Health Canada Canadian Total Diet Study [Internet]. Average Dietary Intakes (μg.Kg Bw/day) of Trace Elements for Canadians in Different Age/sex Groups for Total Diet Study from 1993 to 1999 2003, Health Canada, Ottawa (ON), [cited: 2016 Jan]. Available from:. http://www.hc-sc.gc.ca/fn-an/surveill/total-diet/intake-apport/metal_intake-plomb_apport_93-99-eng.php.
13. INSPQ (Institut national de santé publique du Québec) Étude sur l'établissement de valeurs de référence d'éléments traces et de métaux dans le sang, le sérum et l'urine de la population de la grande région de Québec 2004, Institut national de santé publique du Québec, Québec, Que. Cote: INSPQ-2004-030.
14. IMOA (International Molybdenum Association) Molybdenum Uses 2015, http://www.imoa.info/molybdenum-uses/molybdenum-uses.php.
15. IOM (Institute of Medicine) Dietary Reference Intakes for Vitamin a, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicone, Vanadium, Zinc 2001, http://www.nap.edu/catalog/10026/dietary-reference-intakes-for-vitamin-a-vitamin-k-arsenic-boron-chromium-copper-iodine-iron-manganese-molybdenum-nickel-silicon-vanadium-and-zinc.
16. Kikuchi K., Hamano S., Mochizuki H., Ichida K., Ida H. Molybdenum cofactor deficiency mimics cerebral palsy: differentiating factors for diagnosis. Pediatr. Neurol. 2012 Aug, 47(2):147-149.
17. Koval'skiy V.V., Yarovaya G.A., Shmavonyan D.M. Changes of purine metabolism in man and animals under conditions of molybdenum biogeochemical provinces. Zh. Obshch. Biol. 1961, 22:179-191. (Russian trans.).
18. Murray F.J., Sullivan F.M., Tiwary A.K., Carey S. 90-Day subchronic toxicity study of sodium molybdate dihydrate in rats. Regul. Toxicol. Pharmacol. 2014, 70(3):579-588.
19. Murray F.J., Tyl R.W., Sullivan F.M., Tiwary A.K., Carey S. Developmental toxicity study of sodium molybdate dihydrate administered in the diet to Sprague Dawley rats. Reprod. Toxicol. 2014, 49:202-208.
20. NTP (National Toxicology Program) NTP Technical Report on the Toxicology and Carcinogenesis Studies of Molybdenum Trioxide (Cas No. 1313-27-5) in F344/n Rats and B6C3F1 Mice (Inhalation Studies). 1997. NTP TR 462 1997, US Department of Health and Human Services, NIH Publication No. 97-3378.
21. Novotny J.A., Turnlund J.R. Molybdenum intake influences molybdenum kinetics in men. J. Nutr. 2007 Jan, 137(1):37-42. PubMed PMID: 17182798.
22. OECD SIDS (Organisation for Economic Cooperation and Development Screening Information Dataset) Highly Soluble Molybdenum Salts 2013, Avaialbel from. http://webnet.oecd.org/HPV/UI/SIDS_Details.aspx?id=5c88d62f-4401-4cad-b521-521a4bd710f3.
23. RIVM.(Rijksinstituut voor volksgezondheid en milieu) Baars AJ et al. 2001. Re-evaluation of human-toxicological maximum permissible risk levels. RIVM report no. 711701025, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, March 2001 2001, 75-77. Available at:, or at, (click on Search, type "711701025", then click on document). http://www.rivm.nl/bibliotheek/rapporten/711701025.pdf.
24. Schroeder, Mitchener Toxic effects of trace elements on the reproduction of mice and rats. Archiv. Environ. Health 1971, 23:102-106.
25. Sievers E., Dörner K., Garbe-Schönberg D., Schaub J. Molybdenum metabolism: stable isotope studies in infancy. J. Trace Elem. Med. Biol. 2001, 15(2-3):185-191.
26. Sievers E., Oldigs H.D., Dörner K., Kollmann M., Schaub J. Molybdenum balance studies in premature male infants. Eur. J. Pediatr. 2001, 160(2):109-113.
27. Schultze B., Lind P.M., Larsson A., Lind L. Whole blood and serum concentrations of metals in a Swedish population-based sample. Scand. J. Clin. Lab. Invest. 2014 Mar, 74(2):143-148.
28. State of Washington State of Washington Department of Ecology Product Testing Data. Online Database 2015, Available at:. https://fortress.wa.gov/ecy/ptdbpublicreporting/.
29. Turnlund J.R., Keyes W.R. Plasma molybdenum reflects dietary molybdenum intake. J. Nutr. Biochem. 2004 Feb, 15(2):90-95. PubMed PMID: 14972348.
30. Turnlund J.R., Keyes W.R., Peiffer G.L. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men at five intakes of dietary molybdenum. Am. J. Clin. Nutr. 1995, Oct;62(4):790-796. PubMed PMID: 7572711.
31. Turnlund J.R., Keyes W.R., Peiffer G.L., Chiang G. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men during depletion and repletion. Am. J. Clin. Nutr. 1995, 61:1102-1109.
32. Underwood E.J. Trace Elements in Human and Animal Nutrition 1977, 109-131. Academic Press, New York. fourth ed.
33. U.S.EPA (United States Environmental Protection Agency) Integrated Risk Information System (IRIS). Online. National Center for Environmental Assessment, Washington, DC 1992, (Available on IRIS).
34. US HPD (United States Household Products Database) Online Database. Department of Health and Human Services 2015, Available at:. http://householdproducts.nlm.nih.gov/index.htm.
35. van Esch G.J. Letter to Dr. a. Betz Dd 2 October 1978. RIVM Letter No. U 200/78 Tox VI VE/1b 1978, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
36. Vyskocil A., Viau C. Assessment of molybdenum toxicity in humans. J. Appl. Toxicol. 1999 May-Jun, 19(3):185-192.
37. Werner E., Giussani A., Heinrichs U., Roth P., Greim H. Biokinetic studies in humans with stable isotopes as tracers. Part 2: uptake of molybdenum from aqueous solutions and labelled foodstuffs. Isot. Environ. Health Stud. 1998, 34(3):297-301.
38. Werner E., Roth P., Heinrichs U., Giussani A., Cantone M.C., Zilker T.H., Felgenhauer N., Greim H. Internal biokinetic behaviour of molybdenum in humans studied with stable isotopes as tracers. Isot. Environ. Health Stud. 2000, 36(2):123-132.
39. WHO (World Health Organisation) Molybdenum in Drinking-water. Background Document for Development of WHO Guidelines for Drinking-water Quality 2011, Document No. WHO/SDE/WSH/03.04/11/Rev/1, World Health Organisation.